20
Biophore India Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
One of their notable products is REGADENOSON, with a corresponding US DMF Number 30834.
Remarkably, this DMF maintains an Active status since its submission on September 13, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 08, 2016, and payment made on September 16, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II